Hans-Peter Albert Ostler
Président chez ECTIN RESEARCH AB
Fortune : 349 718 $ au 31/05/2024
Profil
Hans-Peter Albert Ostler is currently the Deputy Chairman at Alligator Bioscience AB and the Chairman at Ectin Research AB.
He is also the Chairman of Improve Tec Hönö AB, and serves as a Director at Ancoria Insurance Ltd., Entreprenörskapital i Sverige AB, Oblique Therapeutics AB, O Mgmt AB, Inorbit Therapeutics AB, RGNT Electric AB, SP HMSO Göteborg AB, and Lennart ekerholms stiftelse.
Additionally, he is a Director at Hoodin AB since 2021.
Previously, he worked as an Independent Director at Promore Pharma AB and as an Independent Director at IRLAB Therapeutics AB from 2016 to 2017.
Mr. Ostler completed his undergraduate and graduate studies at Handelshögskolan i Göteborg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALLIGATOR BIOSCIENCE AB
0,45% | 31/10/2023 | 3 411 884 ( 0,45% ) | 349 718 $ | 31/05/2024 |
Postes actifs de Hans-Peter Albert Ostler
| Sociétés | Poste | Début |
|---|---|---|
| ALLIGATOR BIOSCIENCE AB | Directeur/Membre du Conseil | 01/06/2021 |
| ECTIN RESEARCH AB | Président | 01/05/2022 |
| HOODIN AB | Directeur/Membre du Conseil | 01/01/2021 |
Entreprenörskapital i Sverige AB
 Entreprenörskapital i Sverige AB Investment Banks/BrokersFinance Entreprenörskapital i Sverige AB provides activities of securities and commodity brokers. It attracts companies to support companies in a start-up phase. It is the products of the collective wealth of risk capital experience. It desires to explore new approaches to investing in unlisted companies. It delivers benefits to investors, entrepreneurs, customers, and society. The company was founded by Raymond Peter Wendel on January 12, 2011 and is headquartered in Gothenburg, Sweden. | Directeur/Membre du Conseil | - |
Ancoria Insurance Ltd.
 Ancoria Insurance Ltd. Multi-Line InsuranceFinance Ancoria Insurance Ltd. provides insurance services. It offers life insurance policies and occupational pension schemes. The company was founded by Sievert Larsson in 1987 and is headquartered in Nicosia, Cyprus. | Directeur/Membre du Conseil | - |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Directeur/Membre du Conseil | - |
Inorbit Therapeutics AB
 Inorbit Therapeutics AB Pharmaceuticals: MajorHealth Technology Inorbit Therapeutics AB discovers and develops small molecule therapeutics based on molecules with proven clinical efficacy in humans. The company was founded in 2015 and is headquartered in Moelndal, Sweden. | Directeur/Membre du Conseil | - |
| O Mgmt AB | Corporate Officer/Principal | - |
| SP HMSO Göteborg AB | Directeur/Membre du Conseil | - |
| ░░░░░░░ ░░░ ░░░░░░ ░░ | ░░░░░░░░░░ | - |
Anciens postes connus de Hans-Peter Albert Ostler
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Hans-Peter Albert Ostler
| Handelshögskolan i Göteborg | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ALLIGATOR BIOSCIENCE AB | Health Technology |
| HOODIN AB | Technology Services |
| IRLAB THERAPEUTICS AB | Health Technology |
| ECTIN RESEARCH AB | Health Technology |
| Entreprise privées | 10 |
|---|---|
Ancoria Insurance Ltd.
Ancoria Insurance Ltd. Multi-Line InsuranceFinance Ancoria Insurance Ltd. provides insurance services. It offers life insurance policies and occupational pension schemes. The company was founded by Sievert Larsson in 1987 and is headquartered in Nicosia, Cyprus. | Finance |
Promore Pharma AB
 Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
Entreprenörskapital i Sverige AB
Entreprenörskapital i Sverige AB Investment Banks/BrokersFinance Entreprenörskapital i Sverige AB provides activities of securities and commodity brokers. It attracts companies to support companies in a start-up phase. It is the products of the collective wealth of risk capital experience. It desires to explore new approaches to investing in unlisted companies. It delivers benefits to investors, entrepreneurs, customers, and society. The company was founded by Raymond Peter Wendel on January 12, 2011 and is headquartered in Gothenburg, Sweden. | Finance |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Health Technology |
| O Mgmt AB | |
Inorbit Therapeutics AB
Inorbit Therapeutics AB Pharmaceuticals: MajorHealth Technology Inorbit Therapeutics AB discovers and develops small molecule therapeutics based on molecules with proven clinical efficacy in humans. The company was founded in 2015 and is headquartered in Moelndal, Sweden. | Health Technology |
| Improve Tec Hönö AB | |
RGNT Electric AB
 RGNT Electric AB Motor VehiclesConsumer Durables RGNT Electric AB is a Swedish company that specializes in electric motorcycles. The company is based in Kungsbacka, Sweden. The company's range of motorbikes is both timeless and forward-thinking. RGNT Electric was founded in 2019 by Jonathan Åström. Göran Karlsson has been the CEO of the company since January 12, 2023. | Consumer Durables |
| SP HMSO Göteborg AB | |
| Lennart ekerholms stiftelse | Miscellaneous |
